Lv1
60 积分 2025-03-23 加入
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
5天前
已完结
Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study
8天前
已关闭
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review
8天前
已完结
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review
13天前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
22天前
已完结
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
1个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
2个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
3个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
3个月前
已完结
Duchenne型肌营养不良多学科管理指南
5个月前
已完结
皖公网安备34019202002308
